Haematology 2018

EORTC database: 6675 patients

Not Hodgkin lymphoma: 10 patients

Entered into both early and advanced stage trials: 7 patients

PROSPECTIVE

CVD after therapy for HL: A detailed analysis of 9 collaborative EORTC-LYSA trials

Follow-up data not available: 53 patients

Incomplete treatment information: 566 patients

Clinical report forms: 6039 patients

Dead: 816 patients

Life Situation Questionnaire (LSQ): 4735 patients eligible

Dead: 488 patients

Non-participating centers: 739 patients

RETROSPECTIVE

Address unavailable: 1073 patients

LSQ refusal/no-response: 1004 patients

Maraldo et al, Lancet Hemat 2015

LSQ responders: 1919 patients